Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Essential fatty acids and mental illness.

Krishna Vaddadi1

  • 1Department of Psychological Medicine, Monash Medical Centre, Clayton, Victoria, Australia. vaddadik@hotmail.com

International Review of Psychiatry (Abingdon, England)
|June 17, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rehabilitation psychiatry: moving forward.

International review of psychiatry (Abingdon, England)·2010
Same author

Are we using excessive neuroleptics? An argument for systematic neuroleptic dose reduction in stable patients with schizophrenia with specific reference to clozapine.

International review of psychiatry (Abingdon, England)·2010
Same author

Tardive dyskinesia and essential fatty acids.

International review of psychiatry (Abingdon, England)·2006
Same author

Effective clinical innovation.

Lancet (London, England)·2002

Investigating neuronal phospholipid abnormalities in psychiatric disorders, particularly schizophrenia, reveals potential benefits of omega-3 fatty acid supplementation. Further research into specific fatty acids like GLA and their metabolites is warranted for novel treatment strategies.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Psychiatry

Background:

  • Neuronal phospholipid abnormalities are implicated in psychiatric disorders, notably schizophrenia.
  • Dietary factors, including essential fatty acid (EFA) supplementation, may influence genetically predisposed conditions.
  • Research is shifting focus from omega-6 to omega-3 fatty acids due to dietary imbalances.

Discussion:

  • Eicosapentaenoic acid (EPA) supplementation shows promise in mood disorders.
  • Gamma-linolenic acid (GLA) demonstrated positive outcomes in schizophrenia studies during the 1980s.
  • Future research should explore pure GLA and down-the-chain omega-3 metabolites.

Key Insights:

  • Novel omega-3 derived mediators like resolvins and neuroprotectins are highly bioactive.

Related Experiment Videos

  • These mediators may play a role in psychiatric disorders, though this is currently speculative.
  • Longitudinal, randomized controlled trials are needed to confirm the preventative effects of EFA supplementation.

    • Outlook:

    • Exploring specific omega-3 fatty acids and their metabolites offers potential for novel pharmacological treatments.
    • Understanding the interplay between genetics and diet is crucial for psychiatric illness management.
    • Further investigation into bioactive lipid mediators could unlock new therapeutic avenues for psychiatric conditions.